For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230518:nRSR9274Za&default-theme=true
RNS Number : 9274Z Deutsche Bank AG, Frankfurt 18 May 2023
18 May 2023
Not for distribution, directly or indirectly, in or into the United States or
any jurisdiction in which such distribution would be unlawful
Cheplapharm Arzneimittel GmbH
Post-Stabilisation Notice
Pursuant to Article 6(3) of Commission Delegated Regulation (EU) 2016/1052
supplementing Article 5 of Regulation (EU) No 596/2014 of the European
Parliament and of the Council with regard to regulatory technical standards
for the conditions applicable to buy-back programmes and stabilisation,
Deutsche Bank Aktiengesellschaft (contact: Jeremy Selway, telephone +44 (0)20
7547 5983) hereby gives notice that stabilisation was undertaken by the
Stabilising Manager named below in relation to the offer of the following
securities.
The Securities:
Issuer:
Cheplapharm Arzneimittel GmbH
Guarantor (if any): CheplaFinance 2 GmbH
(with limited recourse)
If Cheplapharm Switzerland will acquire some or all of the assets
subject to the Izac Acquisition, as of the Escrow Release Date,
the Notes will, subject to certain agreed security principles, also
be guaranteed on a senior basis by Cheplapharm Switzerland.
Aggregate nominal amount: EUR 425.000.000
Description: EUR
425,000,000 Senior Secured Notes7.50% due 2030
(RegS ISIN: XS2618867159; 144A ISIN: XS2618869445)
Issue/Reoffer Price: 100
Spread over benchmark: +523 bps
Trading venue(s) on which stabilisation occurred: The International Stock
Exchange Authority Limited
Stabilisation:
Stabilising Manager(s): Deutsche Bank
Aktiengesellschaft
Stabilisation started: 26 April 2023
Stabilisation last occurred: 02 May 2023
For each of the dates during which stabilisation transactions were carried
out, the price range was as follows:
Date: Lowest Price (EUR): Highest Price (EUR):
24/04/2023 100.125 100.125
27/04/2023 100.375 100.375
28/04/2023 100.375 100.625
02/05/2023 100.625 100.625
This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or
dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United
States. The securities referred to above have not been, and will not be,
registered under the United States Securities Act of 1933 and may not be
offered or sold in the United States absent registration or an exemption from
registration. There has not been and will not be a public offer of the
securities in the United States.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END STAFLFLFELITLIV